Opsis Therapeutics

Opsis Therapeutics

Biotechnology Research Madison, Wi, United States 5 employees
Employees
5
Contacts
3
Emails
3
Phones
3

Opsis Therapeutics Overview

Headquarters
Madison, Wi, United States
Phone Number
Available in AeroLeads
Website
opsistx.com
Industry
Biotechnology Research
Employees
5
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Opsis Therapeutics

Opsis Therapeutics is a company focused on advancing the pipeline of cell replacement therapies targeting ocular diseases. Leveraging innovations in induced pluripotent cell (iPSC) generation, retinal cell differentiation, and functional biomaterials, Opsis Therapeutics is developing cell therapies for patients with dry age-related macular degeneration (AMD), inherited macular degenerations (IMDs) and inherited retinal diseases (IRDs). Founded in 2016, Opsis Therapeutics is a joint venture of FUJIFILM Cellular Dynamics and David Gamm, M.D., Ph.D., and is headquartered in Madison, Wisconsin.

Opsis Therapeutics Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
3
75.0% coverage

Opsis Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Lucas Chase Executive Director, R&D at Opsis Therapeutics and Fujifilm Cellular Dynamics, Inc.
Email Phone
Nick Seay Investor & Consultant
Email Phone
Joe Phillips Director, Preclinical Studies at Opsis Therapeutics
View
Carter Cliff
Email Phone

Employees by Management Level

Director 2 profiles
Individual contributor 1 profile

Compare Similar Companies to Opsis Therapeutics